首页> 外文期刊>European Journal of Medicinal Plants >Evaluation of the Ameliorative Property of Vernonia amygdalina Fractions in Streptozotocin Induced Diabetes
【24h】

Evaluation of the Ameliorative Property of Vernonia amygdalina Fractions in Streptozotocin Induced Diabetes

机译:链脲佐菌素诱发的糖尿病患者的扁桃病菌的改善特性的评价

获取原文
           

摘要

Medicinal plants play a major role in the management of Diabetes mellitus especially in developing countries. Aims: The present study examines the bioactive constituents of Vernonia amygdalina and the effect of extract and fractions of Vernonia amygdalina on some biochemical indicators and antioxidant level in Diabetes mellitus management in Wistar rats. Study Design: Multi-arm pre-post interventional study. Place and Duration of Study: Department of Physiology, faculty of basic medical sciences, Delta state university, Abraka. The study lasted for 28 days. Methodology: The fresh Vernonia leaves were air-dried, crushed and soaked in ethanol for 48 hours after which the ethanolic extract was sieved out and allowed to dry. The resultant ethanol-free juice was subjected to liquid-liquid fractionation using solvents of varying polarity. The rats were divided into 7 groups (n=5) as follows, non-diabetic group, diabetic groups (crude, chloroform, ethyl acetate, Benzene and Butanol) received 300 mg/kg Vernonia amygdalina extract and the Metformin group received 50 mg/kg metformin. Results: Administration of Crude ethanolic leaf extracts of Vernonia amygdalina at dose of 300 mg/kg/day produce maximum fall (81.45%) in the fasting glucose level in diabetic rats and decreased aspartate aminotransferase (11%), alanine aminotransferase (82), alkaline phosphatase (21%), Bilirubin levels and triglycerides and low density lipoprptein-cholesterol (17%), while increasing the levels of serum proteins (69%) in the diabetic Wistar rats after 28 days of treatment. Administration of the fractions at 300 mg/kg/day produce a decrease in the fasting glucose level in diabetic rats, Chloroform (65.85%), ethyl acetete (69.65%), Benzene (45.59%) and Butanol (37.31%) respectively and decreased aspartate aminotransferase (11-66%), alanine aminotransferase (77-86%), alkaline phosphatase (60.75%), Bilirubin levels in the diabetic Wistar rats after 28 days of treatment. Conclusion: The finding showed that Vernonia amygdalina extract and fractions reduced the hyperglycaemia induced by streptozotocin in Wistar rats. It possesses significant antioxidant properties and ameliorated the toxic effect of Diabetes mellitus as evident by its effect of biochemical indicators. It also contains bioactive compounds with potent antidiabetic properties.
机译:药用植物在糖尿病的管理中起着重要作用,尤其是在发展中国家。目的:本研究研究了紫星病菌的生物活性成分,以及紫星病菌的提取物和级分对Wistar大鼠糖尿病管理中某些生化指标和抗氧化剂水平的影响。研究设计:多臂前后干预研究。学习地点和持续时间:三角州立大学基础医学系生理学系,阿布拉卡。研究持续了28天。方法:将新鲜的Vernonia叶片风干,压碎并在乙醇中浸泡48小时,然后将乙醇提取物过筛并使其干燥。使用不同极性的溶剂将所得的无乙醇汁液进行液-液分离。将大鼠分为7组(n = 5),分别为非糖尿病组,糖尿病组(粗制,氯仿,乙酸乙酯,苯和丁醇)以300 mg / kg的杏仁核提取物,二甲双胍组以50 mg / kg的剂量服用。公斤二甲双胍。结果:以300 mg / kg / day的剂量施用苦杏仁油的粗乙醇叶提取物可使糖尿病大鼠的空腹血糖水平最大下降(81.45%),并降低天冬氨酸转氨酶(11%),丙氨酸转氨酶(82),碱性磷酸酶(21%),胆红素水平和甘油三酸酯和低密度脂蛋白胆固醇(17%),同时在28天的治疗后增加了糖尿病Wistar大鼠的血清蛋白水平(69%)。以300 mg / kg / day的剂量给予糖尿病大鼠的空腹葡萄糖水平,氯仿(65.85%),乙酸乙酯(69.65%),苯(45.59%)和丁醇(37.31%)分别降低并降低治疗28天后,糖尿病Wistar大鼠的天冬氨酸转氨酶(11-66%),丙氨酸转氨酶(77-86%),碱性磷酸酶(60.75%),胆红素水平。结论:该发现表明苦杏仁Vernonia提取物和级分降低了链脲佐菌素在Wistar大鼠中引起的高血糖症。它具有显着的抗氧化性能,并通过其生化指标的作用明显改善了糖尿病的毒性作用。它还包含具有有效的抗糖尿病特性的生物活性化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号